Actively Recruiting
Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery
Led by Seoul National University Hospital · Updated on 2025-12-26
94
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective randomized controlled trial evaluates whether individualized cardiac index-guided intraoperative hemodynamic management reduces postoperative transient ischemic episodes in pediatric patients undergoing encephaloduroarteriosynangiosis (EDAS) for Moyamoya disease. Patients are randomized 1:1 to goal-directed fluid therapy based on baseline cardiac index versus standard arterial pressure-based management. The primary outcome is the incidence of transient ischemic episodes during hospitalization.
CONDITIONS
Official Title
Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients <18 years undergoing EDAS for Moyamoya disease under general anesthesia
You will not qualify if you...
- ASA physical status 4-5
- Emergency surgery
- Known cardiovascular disease
- Any condition judged inappropriate by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Children's Hospital
Seoul, South Korea
Actively Recruiting
Research Team
J
Jung-Bin Park
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here